NPM1,FLT3-ITD,CEBPA, andc-kitmutations in 312 Chinese patients withde novoacute myeloid leukemia

RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia

(2013) Xiaofei Yang et al.   CLINICAL BIOCHEMISTRY

Age-Specific Distributions of Cytogenetic Subgroups of Acute Myeloid Leukemia: Data Analysis in a Chinese Population

(2012) Long Su et al.   ACTA HAEMATOLOGICA

FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India

(2012) Kanjaksha Ghosh et al.   ANNALS OF HEMATOLOGY

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)

(2011) Friederike Schneider et al.   ANNALS OF HEMATOLOGY

Activated leukemic oncogenes AML1-ETO and c-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition

(2011) A. V. Rulina et al.   BIOCHEMISTRY-MOSCOW

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

(2011) Y. Shen et al.   BLOOD

Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications

(2011) Guido Marcucci et al.   JOURNAL OF CLINICAL ONCOLOGY

Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype

(2011) Torsten Haferlach et al.   LEUKEMIA RESEARCH

A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia—evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients

(2011) Chi-Chiu So et al.   Cancer Genetics

Prognostic Significance ofCEBPAMutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of DoubleCEBPAMutations and the Interaction WithFLT3andNPM1Mutations

(2010) Claire L. Green et al.   JOURNAL OF CLINICAL ONCOLOGY

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication

(2009) A. Renneville et al.   BLOOD

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

(2009) T Pabst et al.   BRITISH JOURNAL OF CANCER

Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China

(2009) Y Cheng et al.   LEUKEMIA

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

(2008) Guo-Rui Ruan et al.   ANNALS OF HEMATOLOGY

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

(2008) Richard F. Schlenk et al.   NEW ENGLAND JOURNAL OF MEDICINE